Analyst Ratings for Amphastar Pharmaceuticals (AMPH)
AMPH Rating Summary
AMPH Price Target Summary
- Highest: $32.00 (BofA Securities)
- Lowest: $25.00 (Piper Sandler)
- Average: $29.40
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$29.40 (+52%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
Avg. $ Target:
$29.40 (+52%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays | Glen Santangelo | New Coverage | Equalweight (N/A) |
30.00 (N/A) |
26.77 (19.34) |
-27.75% | Details |
| 8/12/2025 | Needham » Updated 2/27/2026 |
Serge Belanger | Upgrade | Buy (Hold) |
30.00 (34.00) |
27.36 (19.34) |
-29.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
